Cardiac cachexia causing extensive serous degeneration of bone marrow (Englisch)
- Neue Suche nach: Chan, N.
- Neue Suche nach: Ho, C.
- Neue Suche nach: Yip, S. F.
- Neue Suche nach: Chan, N.
- Neue Suche nach: Ho, C.
- Neue Suche nach: Yip, S. F.
In:
BRITISH JOURNAL OF HAEMATOLOGY
;
178
, 5
;
660-660
;
2017
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Cardiac cachexia causing extensive serous degeneration of bone marrow
-
Beteiligte:
-
Erschienen in:BRITISH JOURNAL OF HAEMATOLOGY ; 178, 5 ; 660-660
-
Verlag:
- Neue Suche nach: John Wiley & Sons Ltd
-
Erscheinungsdatum:01.01.2017
-
Format / Umfang:1 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616 / 616.15
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 178, Ausgabe 5
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 653
-
Issue Information| 2017
- 657
-
Histological assessment at follicular lymphoma progressionTomita, N. et al. | 2017
- 659
-
Richter syndrome presenting as Sister Mary Joseph umbilical noduleMaddy, L. / Campbell, P. J. / Kipp, D. / Rose, H. L. et al. | 2017
- 660
-
Cardiac cachexia causing extensive serous degeneration of bone marrowChan, N. / Ho, C. / Yip, S. F. et al. | 2017
- 661
-
From genetic single candidate gene studies to complex genomics of GvHDBogunia-Kubik, K. / acina, P. et al. | 2017
- 676
-
The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia majorDi Maggio, R. / Maggio, A. et al. | 2017
- 689
-
Advances in understanding the pathogenesis of familial myeloproliferative neoplasmsRumi, E. / Cazzola, M. et al. | 2017
- 699
-
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO groupAlonso-lvarez, S. / Magnano, L. / Alcoceba, M. / Andrade-Campos, M. / Espinosa-Lara, N. / Rodrguez, G. / Mercadal, S. / Carro, I. / Sancho, J. M. / Moreno, M. et al. | 2017
- 709
-
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patientsDann, E. J. / Bairey, O. / Bar-Shalom, R. / Mashiach, T. / Barzilai, E. / Kornberg, A. / Akria, L. / Tadmor, T. / Filanovsky, K. / Abadi, U. et al. | 2017
- 719
-
Clinicopathological analysis of primary splenic diffuse large B-cell lymphomaShimono, J. / Miyoshi, H. / Kiyasu, J. / Sato, K. / Kamimura, T. / Eto, T. / Miyagishima, T. / Nagafuji, K. / Teshima, T. / Ohshima, K. et al. | 2017
- 728
-
Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemiaZhang, X. / Yang, L. / Liu, X. / Nie, Z. / Wang, X. / Pan, Y. / Luo, J. et al. | 2017
- 739
-
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group studyCederleuf, H. / Bjerregrd Pedersen, M. / Jerkeman, M. / Relander, T. / d'Amore, F. / Ellin, F. et al. | 2017
- 747
-
Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre-based Prospective StudyUgai, T. / Matsuo, K. / Sawada, N. / Iwasaki, M. / Yamaji, T. / Shimazu, T. / Sasazuki, S. / Inoue, M. / Kanda, Y. / Tsugane, S. et al. | 2017
- 756
-
Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myelomaKumar, S. K. / Laubach, J. P. / Giove, T. J. / Quick, M. / Neuwirth, R. / Yung, G. / Rajkumar, S. V. / Richardson, P. G. et al. | 2017
- 764
-
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemiaAlvarez-Larrn, A. / Senn, A. / Fernndez-Rodrguez, C. / Pereira, A. / Arellano-Rodrigo, E. / Gmez, M. / Ferrer-Marin, F. / Martnez-Lpez, J. / Camacho, L. / Colomer, D. et al. | 2017
- 772
-
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkersLi, L. / Duan, W. / Zhang, L. / Li, X. / Fu, X. / Wang, X. / Wu, J. / Sun, Z. / Zhang, X. / Chang, Y. et al. | 2017
- 781
-
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myelomaRussignan, A. / Spina, C. / Tamassia, N. / Cassaro, A. / Rigo, A. / Bagnato, A. / Rosan, L. / Bonalumi, A. / Gottardi, M. / Zanatta, L. et al. | 2017
- 794
-
Defective 2antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiencyMitchell, J. L. / Wright, S. / Kazi, S. / Watson, H. G. / Mutch, N. J. et al. | 2017
- 800
-
Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trialKampouraki, E. / Avery, P. J. / Wynne, H. / Biss, T. / Hanley, J. / Talks, K. / Kamali, F. et al. | 2017
- 810
-
Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemiaHelm, L. H. / Berger, G. / Diepstra, A. / Huls, G. / Vellenga, E. et al. | 2017
- 813
-
Validation of the WHO 2016 proposals for Myelodysplastic syndromes patients with the presence of ring sideroblasts but without excess blastsLi, Y. / Cui, R. / Qin, T. / Xu, Z. / Zhang, Y. / Cai, W. / Cui, W. / Liu, J. / Li, B. / Xiao, Z. et al. | 2017
- 816
-
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative studyD'Souza, A. / Pasquini, M. / Logan, B. / Giralt, S. / Krishnan, A. / Antin, J. / Howard, A. / Goodman, S. / Qazilbash, M. / Knust, K. et al. | 2017
- 820
-
A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbiditiesDanilov, A. V. / Lewis, L. D. / Lansigan, F. / Roudaia, L. / Findley, D. L. / Jones, S. Y. / Highhouse, B. / Beaulieu, B. B. / Brown, J. R. et al. | 2017
- 824
-
Type C TP53-CDKN1A pathway dysfunction occurs independently of CDKN1A gene polymorphisms in chronic lymphocytic leukaemia and is associated with TP53 abnormalitiesTracy, I. / Tapper, W. / Parker, A. / Gardiner, A. / Sadullah, S. / Pratt, G. / Copplestone, A. / Oscier, D. / Best, O. G. et al. | 2017